Prodisc C may be safe, effective at 24 months for symptomatic cervical disc disease
Early results of an investigational device exemption clinical trial showed two prodisc C implants may be safe and effective for the treatment of symptomatic cervical disc disease at two levels compared with the Mobi-C implant at 24 months.